Through a comprehensive analysis of transcriptome/proteome datasets and network pharmacology, followed by cell-based experiments, it was demonstrated that GCK is crucial in the hypoglycemic activity of GF5000 and that amino acid metabolism alteration may be the main pathway by which insulin resistance is improved. The gene discussed is GCK; the disease is Insulin resistance.